ARALEZ PHARMACEUTICALS INC. Selling, General and Administrative Expense
ARALEZ PHARMACEUTICALS INC. reported Selling, General and Administrative Expense of $26.50 million for the 3-month period ending 2018-03-31, per its 10-Q filed 2018-05-08.
Discontinued › Expense Statement › Operating Expenses
us-gaap:SellingGeneralAndAdministrativeExpense · last filed 2018-05-08
- ARALEZ PHARMACEUTICALS INC. selling, general and administrative expense for the quarter ending 2018-03-31 was $26.50M, a 14.08% decline year-over-year.
- ARALEZ PHARMACEUTICALS INC. selling, general and administrative expense for the quarter ending 2017-12-31 was $28.81M, a 12.48% decline year-over-year.
- ARALEZ PHARMACEUTICALS INC. selling, general and administrative expense for the quarter ending 2017-09-30 was $24.69M, a 2.98% decline year-over-year.
- ARALEZ PHARMACEUTICALS INC. selling, general and administrative expense for the quarter ending 2017-06-30 was $32.23M, a 41.81% increase year-over-year.
- ARALEZ PHARMACEUTICALS INC. selling, general and administrative expense for fiscal 2017 was $116.57M, a 1.67% decline from fiscal 2016.
- ARALEZ PHARMACEUTICALS INC. selling, general and administrative expense for fiscal 2016 was $118.55M, a 135.47% increase from fiscal 2015.
- ARALEZ PHARMACEUTICALS INC. selling, general and administrative expense for fiscal 2015 was $50.34M, a 399.55% increase from fiscal 2014.
- ARALEZ PHARMACEUTICALS INC. selling, general and administrative expense for fiscal 2014 was $10.08M.
| Period end | Selling, General and Administrative Expense 3 month | Selling, General and Administrative Expense 6 month | Selling, General and Administrative Expense 9 month | Selling, General and Administrative Expense 12 month |
|---|---|---|---|---|
| 2018-03-31 | $26.50M 10-Q · filed 2018-05-08 | $55.31M derived: sum of 2 quarters · filed 2018-05-08 | $79.99M derived: sum of 3 quarters · filed 2018-05-08 | $112.23M derived: sum of 4 quarters · filed 2018-05-08 |
| 2017-12-31 | $28.81M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-14 | $53.49M derived: sum of 2 quarters · filed 2018-03-14 | $85.73M derived: sum of 3 quarters · filed 2018-03-14 | $116.57M 10-K · filed 2018-03-14 |
| 2017-09-30 | $24.69M 10-Q · filed 2017-11-09 | $56.92M derived: sum of 2 quarters · filed 2017-11-09 | $87.77M 10-Q · filed 2017-11-09 | $120.68M derived: sum of 4 quarters · filed 2018-05-08 |
| 2017-06-30 | $32.23M 10-Q · filed 2017-08-09 | $63.08M 10-Q · filed 2017-08-09 | $95.99M derived: sum of 3 quarters · filed 2018-05-08 | $121.44M derived: sum of 4 quarters · filed 2018-05-08 |
| 2017-03-31 | $30.85M 10-Q · filed 2018-05-08 | $63.76M derived: sum of 2 quarters · filed 2018-05-08 | $89.20M derived: sum of 3 quarters · filed 2018-05-08 | $111.94M derived: sum of 4 quarters · filed 2018-05-08 |
| 2016-12-31 | $32.91M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-14 | $58.36M derived: sum of 2 quarters · filed 2018-03-14 | $81.09M derived: sum of 3 quarters · filed 2018-03-14 | $118.55M 10-K · filed 2018-03-14 |
| 2016-09-30 | $25.45M 10-Q · filed 2017-11-09 | $48.18M derived: sum of 2 quarters · filed 2017-11-09 | $85.64M 10-Q · filed 2017-11-09 | $102.32M derived: sum of 4 quarters · filed 2018-03-14 |
| 2016-06-30 | $22.73M 10-Q · filed 2017-08-09 | $60.19M 10-Q · filed 2017-08-09 | $76.87M derived: sum of 3 quarters · filed 2018-03-14 | $89.08M derived: sum of 4 quarters · filed 2018-03-14 |
| 2016-03-31 | $37.46M 10-Q · filed 2017-05-09 | $54.14M derived: sum of 2 quarters · filed 2018-03-14 | $66.35M derived: sum of 3 quarters · filed 2018-03-14 | $84.54M derived: sum of 4 quarters · filed 2018-03-14 |
| 2015-12-31 | $16.68M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-14 | $28.89M derived: sum of 2 quarters · filed 2018-03-14 | $47.08M derived: sum of 3 quarters · filed 2018-03-14 | $50.34M 10-K · filed 2018-03-14 |
| 2015-09-30 | $12.21M 10-Q · filed 2016-11-08 | $30.40M derived: sum of 2 quarters · filed 2016-11-08 | $33.66M 10-Q · filed 2016-11-08 | |
| 2015-06-30 | $18.19M 10-Q · filed 2016-08-09 | $21.46M 10-Q · filed 2016-08-09 | ||
| 2015-03-31 | $3.26M 10-Q · filed 2016-05-10 | |||
| 2014-12-31 | $10.08M 10-K · filed 2017-03-13 |